Molecular mechanisms for the subversion of MyD88 signaling by TcpC from virulent uropathogenic Escherichia coli

The Toll/IL-1 receptor (TIR) domains are crucial signaling modules during innate immune responses involving the Toll-like receptors (TLRs) and IL-1 receptor (IL-1R). Myeloid differential factor 88 (MyD88) is a central TIR domain-containing adapter molecule responsible for nearly all TLR-mediated signaling and is targeted by a TIR domain-containing protein C (TcpC) from virulent uropathogenic Escherichia coli, a common human pathogen. The mechanism of such molecular antagonism has remained elusive. We present the crystal structure of the MyD88 TIR domain with distinct loop conformations that underscore the functional specialization of the adapter, receptor, and microbial TIR domains. Our structural analyses shed light on the genetic mutations at these loops as well as the Poc site. We demonstrate that TcpC directly associates with MyD88 and TLR4 through its predicted DD and BB loops to impair the TLR-induced cytokine induction. Furthermore, NMR titration experiments identify the unique CD, DE, and EE loops from MyD88 at the TcpC-interacting surface, suggesting that TcpC specifically engages these MyD88 structural elements for immune suppression. These findings thus provide a molecular basis for the subversion of TLR signaling by the uropathogenic E. coli virulence factor TcpC and furnish a framework for the design of novel therapeutic agents that modulate immune activation.

[1]  M. Shirakawa,et al.  Molecular analysis of the binding mode of Toll/interleukin-1 receptor (TIR) domain proteins during TLR2 signaling. , 2012, Molecular immunology.

[2]  S. Vogel,et al.  Targeting Toll-like Receptor (TLR) Signaling by Toll/Interleukin-1 Receptor (TIR) Domain-containing Adapter Protein/MyD88 Adapter-like (TIRAP/Mal)-derived Decoy Peptides* , 2012, The Journal of Biological Chemistry.

[3]  A. Bowie,et al.  Structures of the HIN domain:DNA complexes reveal ligand binding and activation mechanisms of the AIM2 inflammasome and IFI16 receptor. , 2012, Immunity.

[4]  Weihong Zhou,et al.  Structural Insights into TIR Domain Specificity of the Bridging Adaptor Mal in TLR4 Signaling , 2012, PloS one.

[5]  C. Tung,et al.  The Brucella TIR-like protein TcpB interacts with the death domain of MyD88. , 2012, Biochemical and biophysical research communications.

[6]  Anne-Sophie de Smet,et al.  Identification of Interaction Sites for Dimerization and Adapter Recruitment in Toll/Interleukin-1 Receptor (TIR) Domain of Toll-like Receptor 4* , 2011, The Journal of Biological Chemistry.

[7]  S. Cusack,et al.  Structural Basis for the Activation of Innate Immune Pattern-Recognition Receptor RIG-I by Viral RNA , 2011, Cell.

[8]  P. Simpson,et al.  Yersinia pestis TIR-domain protein forms dimers that interact with the human adaptor protein MyD88. , 2011, Microbial pathogenesis.

[9]  F. DiMaio,et al.  Crystal structure of Toll-like receptor adaptor MAL/TIRAP reveals the molecular basis for signal transduction and disease protection , 2011, Proceedings of the National Academy of Sciences.

[10]  J. Lakowicz,et al.  Targeting TLR4 Signaling by TLR4 Toll/IL-1 Receptor Domain-Derived Decoy Peptides: Identification of the TLR4 Toll/IL-1 Receptor Domain Dimerization Interface , 2011, The Journal of Immunology.

[11]  B. Kobe,et al.  Structural and functional analysis of a plant resistance protein TIR domain reveals interfaces for self-association, signaling, and autoregulation. , 2011, Cell host & microbe.

[12]  Joseph M. Connors,et al.  Oncogenically active MYD88 mutations in human lymphoma , 2011, Nature.

[13]  T. Miethke,et al.  Inhibition of TIR Domain Signaling by TcpC: MyD88-Dependent and Independent Effects on Escherichia coli Virulence , 2010, PLoS pathogens.

[14]  T. Miethke,et al.  Microbial Toll/interleukin 1 receptor proteins: a new class of virulence factors. , 2010, International journal of medical microbiology : IJMM.

[15]  T. Xiao Subversion of Innate Immune Signaling Through Molecular Mimicry , 2010, Journal of Clinical Immunology.

[16]  Y. Lo,et al.  Helical assembly in the MyD88:IRAK4:IRAK2 complex in TLR/IL-1R signaling , 2010, Nature.

[17]  Randy J. Read,et al.  Acta Crystallographica Section D Biological , 2003 .

[18]  Vincent B. Chen,et al.  Correspondence e-mail: , 2000 .

[19]  E. Santelli,et al.  The crystal structure of a TIR domain from Arabidopsis thaliana reveals a conserved helical region unique to plants , 2009, Protein science : a publication of the Protein Society.

[20]  M. Shirakawa,et al.  Structural basis for the multiple interactions of the MyD88 TIR domain in TLR4 signaling , 2009, Proceedings of the National Academy of Sciences.

[21]  G. Splitter,et al.  Brucella TIR Domain-containing Protein Mimics Properties of the Toll-like Receptor Adaptor Protein TIRAP* , 2009, Journal of Biological Chemistry.

[22]  N. Klopp,et al.  Rare TLR2 mutations reduce TLR2 receptor function and can increase atopy risk , 2009, Allergy.

[23]  P. Nordlund,et al.  The Crystal Structure of the Human Toll-like Receptor 10 Cytoplasmic Domain Reveals a Putative Signaling Dimer* , 2008, Journal of Biological Chemistry.

[24]  A. Wieser,et al.  Subversion of Toll-like receptor signaling by a unique family of bacterial Toll/interleukin-1 receptor domain–containing proteins , 2008, Nature Medicine.

[25]  Carsten Kutzner,et al.  GROMACS 4:  Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. , 2008, Journal of chemical theory and computation.

[26]  R. Ugalde,et al.  Brucella Control of Dendritic Cell Maturation Is Dependent on the TIR-Containing Protein Btp1 , 2008, PLoS pathogens.

[27]  K. Shibata,et al.  Regulation of MyD88-Dependent Signaling Events by S Nitrosylation Retards Toll-Like Receptor Signal Transduction and Initiation of Acute-Phase Immune Responses , 2007, Molecular and Cellular Biology.

[28]  Grazia Gallo,et al.  Pivotal Advance: Inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compound , 2007, Journal of leukocyte biology.

[29]  John Calvin Reed,et al.  Characterization of a TIR-like protein from Paracoccus denitrificans. , 2007, Biochemical and biophysical research communications.

[30]  A. Bowie,et al.  The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling , 2007, Nature Reviews Immunology.

[31]  M. Fenton,et al.  Cutting Edge: Differential Inhibition of TLR Signaling Pathways by Cell-Permeable Peptides Representing BB Loops of TLRs1 , 2007, The Journal of Immunology.

[32]  Giorgio Sirugo,et al.  A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis , 2007, Nature Genetics.

[33]  Ashish,et al.  Structural and Functional Evidence for the Role of the TLR2 DD Loop in TLR1/TLR2 Heterodimerization and Signaling* , 2006, Journal of Biological Chemistry.

[34]  I. Wilson,et al.  Details of Toll-like receptor:adapter interaction revealed by germ-line mutagenesis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[35]  S. Fields,et al.  Binding specificity of Toll‐like receptor cytoplasmic domains , 2006, European journal of immunology.

[36]  Ruchi M. Newman,et al.  Identification and Characterization of a Novel Bacterial Virulence Factor That Shares Homology with Mammalian Toll/Interleukin-1 Receptor Family Proteins , 2022 .

[37]  J. Hawiger,et al.  Interactive Sites in the MyD88 Toll/Interleukin (IL) 1 Receptor Domain Responsible for Coupling to the IL1β Signaling Pathway* , 2005, Journal of Biological Chemistry.

[38]  M. Fenton,et al.  Differential Involvement of BB Loops of Toll-IL-1 Resistance (TIR) Domain-Containing Adapter Proteins in TLR4- versus TLR2-Mediated Signal Transduction 1 , 2005, The Journal of Immunology.

[39]  Zukang Feng,et al.  Automated and accurate deposition of structures solved by X-ray diffraction to the Protein Data Bank. , 2004, Acta crystallographica. Section D, Biological crystallography.

[40]  J. Khan,et al.  Crystal Structure of the Toll/Interleukin-1 Receptor Domain of Human IL-1RAPL* , 2004, Journal of Biological Chemistry.

[41]  Shizuo Akira,et al.  Toll-like receptor signalling , 2004, Nature Reviews Immunology.

[42]  I. Bataronov,et al.  Processing of X-Ray Diffraction Data in Structure Investigations of Amorphous Metal Oxides , 2004 .

[43]  N. Gay,et al.  Structural Complementarity of Toll/Interleukin-1 Receptor Domains in Toll-like Receptors and the Adaptors Mal and MyD88* , 2003, Journal of Biological Chemistry.

[44]  G. Cheng,et al.  Common Interaction Surfaces of the Toll-Like Receptor 4 Cytoplasmic Domain Stimulate Multiple Nuclear Targets , 2003, Molecular and Cellular Biology.

[45]  A. Aderem,et al.  Cutting Edge: A Toll-Like Receptor 2 Polymorphism That Is Associated with Lepromatous Leprosy Is Unable to Mediate Mycobacterial Signaling1 , 2003, The Journal of Immunology.

[46]  J. Banchereau,et al.  Pyogenic Bacterial Infections in Humans with MyD88 Deficiency , 2003, Science.

[47]  Liang Tong,et al.  An extensively associated dimer in the structure of the C713S mutant of the TIR domain of human TLR2. , 2002, Biochemical and biophysical research communications.

[48]  Dirk E. Smith,et al.  Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction , 2001, Nature.

[49]  L. Tong,et al.  Structural basis for signal transduction by the Toll/interleukin-1 receptor domains , 2000, Nature.

[50]  S. Dower,et al.  Identification of Two Major Sites in the Type I Interleukin-1 Receptor Cytoplasmic Region Responsible for Coupling to Pro-inflammatory Signaling Pathways* , 2000, The Journal of Biological Chemistry.

[51]  S. Akira,et al.  Unresponsiveness of MyD88-deficient mice to endotoxin. , 1999, Immunity.

[52]  P. Ricciardi-Castagnoli,et al.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. , 1998, Science.

[53]  S. Akira,et al.  Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. , 1998, Immunity.

[54]  F. Martinon,et al.  MyD88, an Adapter Protein Involved in Interleukin-1 Signaling* , 1998, The Journal of Biological Chemistry.

[55]  C. Janeway,et al.  Innate immune recognition. , 2002, Annual review of immunology.

[56]  Z. Otwinowski,et al.  [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.